<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND AND PURPOSE: We characterized the differential effect of the NR2B subunit <z:chebi fb="68" ids="48706">antagonist</z:chebi> ifenprodil in the induction of activity-dependent long-term potentiation (LTP) and of postischemic LTP as well as in the neuronal damage induced by focal <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: Intracellular recordings were obtained from rat corticostriatal slice preparations </plain></SENT>
<SENT sid="2" pm="."><plain>High-frequency stimulation of corticostriatal fibers was used as a LTP-inducing protocol </plain></SENT>
<SENT sid="3" pm="."><plain>In vitro <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> was induced by oxygen and <z:chebi fb="105" ids="17234">glucose</z:chebi> deprivation </plain></SENT>
<SENT sid="4" pm="."><plain>In vivo <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> was induced by permanent middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> </plain></SENT>
<SENT sid="5" pm="."><plain>Intracellular recordings were also performed in the ischemic penumbra </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: <z:chebi fb="68" ids="48706">Antagonists</z:chebi> selectively targeting N-<z:chebi fb="36" ids="29309">methyl</z:chebi>-d-<z:chebi fb="0" ids="29995">aspartate</z:chebi> receptors containing the NR2B subunit blocked postischemic LTP without affecting activity-dependent LTP </plain></SENT>
<SENT sid="7" pm="."><plain>In a model of focal <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>, blockade of NR2B subunit in vivo caused reduction of brain damage, amelioration of neurological outcome, and normalization of the synaptic levels of NR2B subunits </plain></SENT>
<SENT sid="8" pm="."><plain>Moreover, the antagonism of NR2B subunit was able to rescue the activity-dependent LTP in the ischemic penumbra </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: We suggest that NR2B subunits contribute to the striatal damage caused by in vivo and in vitro <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> and play a critical role in the induction of postischemic LTP as well as in the suppression of activity-dependent LTP in the ischemic penumbra </plain></SENT>
</text></document>